Her research has focused on understanding the effects of pharmaceutical regulation, the pharmaceutical manufacturers' strategic behaviors (i.e., pricing, innovating and advertising) and the welfare effects on patients. For example, the pros and cons of granting market exclusivity to incremental innovations on pharmaceuticals, how the newly discovered clinical information affect physicians’ prescription behaviors. Her research has been published in Health Economics, Economics Letters, American Journal of Health Economics, China Economic Review, The Oxford Handbook of Venture Capital, etc. She has been invited for presentation at international conferences in industrial organization and health economics, such as IIOC, EARIE, and ASHEcon, etc.
New Publications
l Pharmaceuticals, Incremental Innovation and Market Exclusivity, International Journal of Industrial Organization, Volume 87, March 2023, ISSN 0167－7187, https://doi.org/10.1016/j.ijindorg.2023.102922.
l Impact of Antitrust Regulations on Firm Market Value－Evidence from Chinese and U.S. Internet Platforms, (with Yong Huang, Yanhua Zhang and Shan Zhao), 2024. forthcoming at Review of Industrial Organization.
Working Papers
l Has the Shortened Drug Distribution Chain Cut Drug Prices? Evidence from the Two－Invoice System in China, (with Xiaoxi Li, Fanyu Liu and Jianye Yan), October 2023.